ConductScience.org, home

Comparison · NCT00294658-e2169e0b

Thymectomy Plus Prednisone vs Prednisone Alone: Number of Patients With at Least One Serious Adverse Events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Thymectomy Plus Prednisone vs Prednisone Alone: Number of Patients With at Least One Serious Adverse Events. Trial comparisons, record NCT00294658-e2169e0b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00294658-e2169e0b

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3790.2710.499wilson
Risk in group 20.550.4250.669wilson
Risk difference, group 1 minus group 2-0.171-0.3310.00256newcombe hybrid score
Risk ratio, group 1 over group 20.6890.4691.01log
Odds ratio, group 1 over group 20.4990.2451.02log
Number needed to treat, for one fewer participant with the outcome on Thymectomy Plus Prednisone than on Prednisone Alone5.84from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Thymectomy Plus PrednisoneProcedure: Extended Transsternal Thymectomy plus prednisone treatment~thymectomy: The thymectomy will be performed as soon as possible after randomization.2566OG000
Group 2Prednisone AloneDrug: prednisone alone protocol~prednisone: Prednisone regimen will be every other day, starting at 10mg. The dose will increase by 10mg every 2 days to a target dose.3360OG001

Outcome

Type
SECONDARY
Title
Number of Patients With at Least One Serious Adverse Events
Description
Number of participant who experienced at least one serious adverse events over 3 years: Thymectomy plus prednisone n=25 (out of 66); Prednisone alone n=33 (out of 60)
Time frame
baseline to 3 years
Population

Source ClinicalTrials.gov

Trial

Title
Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
NCT number
NCT00294658
Phases
PHASE3
Conditions
Myasthenia Gravis
Interventions
thymectomy plus prednisone, prednisone alone
Lead sponsor
University of Alabama at Birmingham
Results first posted
2017-01-16

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00294658-e2169e0b